The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Morozova T.E.

Institute of Professional Education, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia

Gontarenko S.V.

Kafedra klinicheskoĭ farmakologii i farmakoterapii IPO, GBOU VPO "Pervyĭ MGMU im. I.M. Sechenova" Minzdrava Rossii, Moskva

Kuz'mina E.R.

Kafedra klinicheskoĭ farmakologii i farmakoterapii IPO, GBOU VPO "Pervyĭ MGMU im. I.M. Sechenova" Minzdrava Rossii, Moskva

Principles of choice of an angiotensin-converting enzyme inhibitor: Specific features of perindopril

Authors:

Morozova T.E., Gontarenko S.V., Kuz'mina E.R.

More about the authors

Journal: Therapeutic Archive. 2014;86(9): 115‑118

Read: 40080 times

Download PDF (RU)
Contact the author
Table of contents

PRINCIPLES OF CHOICE OF AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR: SPECIFIC FEATURES OF PERINDOPRIL
PRINCIPLES OF CHOICE OF AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR: SPECIFIC FEATURES OF PERINDOPRIL

To cite this article:

Morozova TE, Gontarenko SV, Kuz'mina ER. Principles of choice of an angiotensin-converting enzyme inhibitor: Specific features of perindopril. Therapeutic Archive. 2014;86(9):115‑118. (In Russ.)

МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Inte­rnational multicenter randomized double-blind placebo-controlled study asse­ssing the effi­cacy and safety of sequential therapy with Mexi­dol and Mexi­dol FORTE 250 in patients with chro­nic brain ischemia (MEMO): suba­nalysis in patients with arte­rial hype­rtension. Russian Journal of Preventive Medi­cine. 2024;(10):72-83
Morphofunctional and biochemical dete­rminants of endo­thelial function in patients with a new coro­navirus infe­ction COVID-19. Russian Journal of Preventive Medi­cine. 2024;(10):90-96
Changes in the lipid profile, stru­ctural and functional states of blood vessels in patients with lymphomas and cardiovascular toxic risks during the chemotherapy. Russian Journal of Preventive Medi­cine. 2024;(10):117-124
The technology of indu­ction of physiological keto­sis in asthenia of various origins and decreased resi­stance to cognitive and physical acti­vity. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):48-54
The significance of exogenous nitrate and nitrite of plant origin for vascular health. Russian Journal of Preventive Medi­cine. 2024;(11):141-146
Predictors of Enga­gement and Active participation of Patients with Unco­ntrolled Hype­rtension in the Tele­health Surveillance Program. Russian Journal of Preventive Medi­cine. 2024;(12):37-43
Features of arte­rial blood flow velo­city characteristics in endo­thelial dysfunction. Russian Journal of Preventive Medi­cine. 2024;(12):100-106
Long-term outcomes in patients after hospital treatment for COVID-19 (three-year follow-up data). Russian Journal of Preventive Medi­cine. 2024;(12):114-121
Asso­ciation of the subclinical athe­rosclerosis with addi­tional risk factors for chro­nic non-communicable diseases. Russian Journal of Preventive Medi­cine. 2024;(12):151-155
Personalized approach to treatment choice using a digi­tal profile of patient with cardiovascular diseases: the features of clinical deci­sion-making support service. Russian Cardiology Bulletin. 2024;(4-2):105-112
Abstract:

Angiotensin-converting enzyme (ACE) inhibitors, a large and heterogeneous group of drugs whose representatives have significant intergroup differences, occupy a special place among many classes of antihypertensive agents. This review focuses on the properties and effects of perindopril, which set off it from other ACE inhibitors, going beyond the scope of the classic effects of this group of drugs.

Keywords:

hypertension
renin-angiotensin-aldosterone system
angiotensin-converting enzyme inhibitors
perindopril
dyslipidemia
carbohydrate metabolic disturbances
cognitive functions
endothelial dysfunction
endothelial function
cardiovascular diseases
hypertension
renin-angiotensin-aldosterone system
angiotensin-converting enzyme inhibitors
perindopril
dyslipidemia
carbohydrate metabolic disturbances
cognitive functions
endothelial dysfunction
endothelial function

Authors:

Morozova T.E.

Institute of Professional Education, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia

Gontarenko S.V.

Kafedra klinicheskoĭ farmakologii i farmakoterapii IPO, GBOU VPO "Pervyĭ MGMU im. I.M. Sechenova" Minzdrava Rossii, Moskva

Kuz'mina E.R.

Kafedra klinicheskoĭ farmakologii i farmakoterapii IPO, GBOU VPO "Pervyĭ MGMU im. I.M. Sechenova" Minzdrava Rossii, Moskva

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.